Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus vs MMF for LVH Regression in Renal Transplant
NCT03415750Phase 4Completed
- Start
- Nov 2016
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of everolimus in left ventricular hypertrophy (LVH) (2 arms). Primary endpoint: Reduction of Left Ventricular Hypertrophy at 12 months. Started Nov 2016; status: completed.
02
Drugs
everolimus
03
Conditions
left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT03415750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03415750.